A study to evaluate ASP0367 in participants with primary mitochondrial myopathy

Trial Identifier: 0367-CL-1201
Sponsor: Astellas Pharma Inc.
Start Date: May 2021
Primary Completion Date: May 2024
Study Completion Date: May 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, California La Jolla, California, United States, 92093
United States, California Stanford, California, United States, 94305
United States, Colorado Aurora, Colorado, United States, 80045
United States, Massachusetts Boston, Massachusetts, United States, 02114
United States, New York New York, United States, 10032
United States, Ohio Akron, Ohio, United States, 44308
United States, Ohio Cleveland, Ohio, United States, 44195
United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19104
United States, Texas Houston, Texas, United States, 77030
United States, Washington Seattle, Washington, United States, 98105